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Abstract
The aim of the paper is to analyse the relationships between the openness degree of companies and their 1) context 
features, 2) R&D organization and 3) financial performances. The openness degree is defined after a pecuniary approach, 
involving all the transactions in the innovation market. Hypotheses are formulated and, then, tested on a sample of 126 
world top R&D spending bio-pharmaceutical companies for the period 2008-2012. Open innovation is more pervasive 
among small and young companies, for most of which it represents the very core business. Inbound and outbound 
practices have a similar diffusion in terms of number of companies adopting them, but the cumulative values of inbound 
flows are higher, whereas outbound flows are more relevant when compared to the total business of the firms. Inbound 
practices are substitutive to internal R&D activities, while outbound ones are complementary to internal development. 
The performances of companies have an inverted-U shape trend versus inbound practices and a fundamentally decreasing 
trend versus outbound ones.
Keywords: open innovation; inbound open innovation; outbound open innovation; r&d organization; financial performances; 
bio-pharmaceutical industry.
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Introduction
Since 2003, when Chesbrough introduced the open 
innovation (OI) paradigm, organizations are becoming more 
and more aware that they are unable to hold in-house all 
the competencies they require, thus forcing them to open 
up their research and development (R&D) processes 
through pooling of collaborative activities and/or trading of 
intellectual property (IP) rights (Gassmann, 2006; West and 
Gallagher, 2006). 
Open innovation has been one of the most discussed topics 
in innovation management literature in the last decade, with 
different approaches and different results. Academic research 
on open innovation is dominated by case studies or project 
experiences on how it is implemented and organized within 
firms (e.g., Dodgson et al., 2006), and survey studies on the 
adoption and performance implications of OI strategies 
(e.g., Laursen and Salter, 2006). Although practice and 
theory seem to indicate that the open innovation approach 
is beneficial for companies, innovation measurement is still 
looking for an appropriate metrics system that monitors the 
investments and the effects of open versus closed innovation 
approaches, in order to help companies to find their right 
balance. The measurement of the value of open innovation 
activities is increasingly important and metrics systems are 
not yet adapted to monitor and measure the value of such 
activities. Only specific measurement systems allow for the 
successful implementation of open innovation and support 
the right capabilities (Enkel and Lenz, 2009).
In order to fill such a gap, we suggested a pecuniary definition 
of openness, based on the economic and financial flows that 
OI transactions generate (Michelino et al., 2014a). Starting 
from such definition, we investigate the relations between 
the adoption of open innovation modalities, the structural 
configurations of companies and their performances.
In particular, the aim of the paper is to analyse the relationship 
between the openness degree of companies and a set of 
variables linked to context features, R&D organization and 
financial performances. Our research questions are: 1) how 
the adoption of OI practices can be linked to the size and the 
age of companies; 2) how inbound and outbound practices 
are related to each other and to internal R&D activities; 
3) how the adoption of OI practices is linked to financial 
performances of companies.
We tested our hypotheses on a sample of 126 world top 
R&D spending bio-pharmaceutical companies selected from 
The 2011 EU Industrial R&D Investment Scoreboard, for 
which we collected annual report data for the five-years 
period 2008-2012, for a total of 630 statistical units.
In section 2, literature review is reported, with the 
main contributions on the relationships between open 
innovation and the other phenomena under study, and 
hypotheses are formulated. The description of the sample 
and the operationalization of the constructs are provided in 
section 3. Section 4 shows the results and conclusions are 
drawn in section 5.
Literature review and development of the hypotheses
Context features
The size of the firm is used by various studies as a 
variable potentially influencing open innovation adoption. 
In particular, many literature contributions (Chesbrough, 
2003; Chesbrough and Crowther, 2006) indicate that the 
new innovation management paradigm is more intensively 
adopted by large firms.
Different studies (Laursen and Salter, 2006; Keupp and 
Gassmann, 2009) found a positive relationship between 
the firm size and OI breadth and depth; Faems et al. 
(2010) detected a significant positive relationship between 
company size and alliance portfolio diversity. Schroll and 
Mild (2011) found that firm size has a strong correlation 
with the adoption of OI practices and also Bianchi et al. 
(2011) found that the largest firms implement organizational 
modes of open innovation on average 1,5 times more than 
the medium-sized and the smallest ones. Further, the study 
conducted by Inauen and Schenker-Wicki (2011) reveals 
statistically significant correlations between company size 
and cooperation intensity with regard to competitors, 
cross-industry firms, consulting firms and universities and 
Sandulli et al. (2012) found that large corporations are more 
likely to collaborate in the innovation process. 
Different results are provided by Barge-Gil (2010) who 
found that open innovators are smaller than semi-
open ones and larger than closed innovators, precluding 
a general conclusion on the relationship between 
openness and firm size.
No support for a linear relation between size and openness 
is provided by Podmetina et al. (2011), who found that 
companies of different size, rather than having different 
degrees of openness, adopt different open business models, 
the smallest firms being more active in technology acquisition, 
the largest ones in technology commercialization.
66
ISSN: 0718-2724. (http://www.jotmi.org) 
Journal of Technology Management & Innovation © Universidad Alberto Hurtado, Facultad de Economía y Negocios.
J. Technol. Manag. Innov. 2014, Volume 9, Issue 3
R&D organization
Empirical studies examining OI adoption modalities have 
constantly found that companies perform more inbound 
than outbound activities even if, by definition, every inbound 
effort from one organization should generate a reciprocal 
outbound effort from another one (Chesbrough and 
Crowther, 2006).
Van der Meer (2007) describes Dutch firms as reluctant to 
take part in the use of exporting mechanisms (i.e. outbound 
practices), with only 54% highly innovative companies using 
them vs. 74% adopting importing mechanisms (i.e. inbound 
practices). Similarly, van de Vrande et al. (2009), using the 
concept of technology exploration and exploitation - 
respectively linked to inbound and outbound - found that 
exploitation activities are pursued by less than 30% of 
their sample, whereas exploration ones were adopted by 
more than 90%. Further, Schroll and Mild (2011) found that 
companies adopt more inbound cooperation (4,03 on a 
seven-point Likert scale) than outbound activities (2,92).
Similar results are provided in contributions focused on 
specific industries: the studies of Chiaroni et al. (2009) and 
Bianchi et al. (2011) in the bio-pharmaceutical industry 
highlight that more than 60% of the OI activities pursued by 
companies are linked to inbound practices. The same findings 
are also obtained in the German automotive industry, where 
Ili et al. (2010) found that only one supplier in the sample of 
42 companies was actively exploiting unused patents, which 
were not suitable to its portfolio.
In his special issue on open innovation, Huizingh (2011) gives 
different explanations to the fact that empirical studies find 
so much more use of inbound OI. One possibility is that 
while many organizations use external knowledge, only a 
few provide it; other potential explanations are that either 
the measurement scales, the respondents, or the samples 
in these studies are biased. He also argues that further 
research could clarify this issue.
From all the previous observations, it follows that inbound 
activities are generally more frequent than outbound ones.
Hp. 3: The adoption of inbound activities is higher than the 
adoption of outbound activities.
Other researchers have focused on the question of whether 
and how much SMEs are using OI. In their study on Dutch 
SMEs, van de Vrande et al. (2009) found that larger SMEs 
have higher levels of adoption than smaller ones. Lee et 
al. (2010) explain the reduced openness of SMEs through 
lack of infrastructure and financial resources. Furthermore, 
Idrissia et al. (2012) found that the increase in size helps 
SMEs to move from a closed cluster to interactive, user, and 
open clusters.
From all the previous considerations, we would expect that 
size has a positive impact on the likelihood of adopting open 
innovation strategies, since larger firms have a stronger 
technological position and greater resources if compared to 
smaller ones.
Hp. 1: Firm size positively influences the adoption of open 
innovation.
The second context feature we analysed is firm age. Such a 
variable can be related to firm experience and learning, and 
is commonly used in empirical studies of innovation (Kumar 
and Saqib, 1996).
Different scholars found that age does not seem to be a 
predictor of openness degree (Keupp and Gassmann, 2009; 
Schroll and Mild, 2011). On the contrary, Teirlinck and 
Poelmans (2012) found that different relationships between 
age and openness degree can be found in different industries: 
cooperating firms in pharmaceuticals tend to be relatively 
young, whereas cooperation in basic chemicals takes place 
in longer established companies. Moreover, Idrissia et al. 
(2012) suggest that age is a significant variable to explain the 
likelihood that SMEs move from closed to open clusters: the 
younger the company, the lower the likelihood for SMEs to 
be in an open cluster. 
Thus, we expect that age has a positive impact on the 
likelihood of adopting open innovation strategies, since aging 
provides companies with experience needed to forge more 
relations and trust with external partners.
Hp. 2: Firm age positively influences the adoption of open 
innovation.
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more on R&D and also Podmetina et al. (2011) found a 
significantly higher value of R&D intensity for the companies 
developing open innovations.
However, none of the above scholars distinguished between 
the inbound and outbound modes of OI. An exception is the 
study by Schroll and Mild (2011). The authors found that, 
generally, open innovation seems to be a complement to 
internal R&D but that an increased use of inbound activities 
is employed as a substitute for internal R&D. Hence, 
inbound open innovation activities can reduce the R&D 
intensity of a company.
From all the previous considerations, it is possible to 
hypothesize a complementarity between the investment in 
internal R&D activities and open innovation adoption, both 
because higher levels of internal R&D imply higher level 
of absorptive capacity and thus favour inbound practices 
and because higher levels of internal R&D generate more 
innovations that can be leveraged by the means of outbound 
open innovation. 
Hp. 5a: Inbound open innovation is complementary to 
internal R&D activities.
Hp. 5b: Outbound open innovation is complementary to 
internal R&D activities.
Financial performances
The impact of open innovation on firms’ financial 
performances has been explored by different studies. 
Dahlander and Gann (2007) argue that it is not true that 
“the more openness, the better” since it can be costly and 
it is not always easy to have a high degree of openness. 
Indeed, the approach chosen by companies should depend 
on its coherence with the strategic, organizational and 
managerial contexts and on an acceptable balance between 
the benefits and costs.
Some contributions support the existence of a positive 
relationship between OI and firm performances. 
Collecting survey data from Taiwanese electronic-product 
manufacturers, Hung and Chiang (2010) found a positive 
relationship between open innovation proclivity and firm 
performances measured through the Wiklund and Shepherd’s 
(2003) scale. Ju et al. (2013) explored the relationships among 
open innovation processes, entrepreneurial orientation, 
and organizational performances (innovation and financial) 
of SMEs. Their empirical results reveal that the inbound 
process is positively related to both performance outcomes, 
the outbound process to financial performance, and the 
coupled process to innovation performance.
However, it is possible to hypothesize that the adoption 
level of outbound activities can be influenced by that of 
inbound ones. In this line, Schroll and Mild (2011) found 
that the more a company adopts inbound OI methods, the 
more it will also adopt outbound ones. As a matter of fact, 
if a firm is using inbound activities for additional creation of 
innovations, it is probable that it will leverage unused parts 
of its increased pool of innovations and IP by the means of 
outbound innovation. 
Hence, we expect a higher likelihood of pursuing outbound 
practices when inbound open innovation is adopted.
Hp. 4: The adoption of inbound open innovation positively 
influences the adoption of outbound open innovation.
One of the issues that is most often discussed in empirical 
OI literature is the relationship between the internal R&D 
activities of a firm and the level of open innovation adoption. 
From one hand, internal R&D is usually employed as a 
proxy for absorptive capacity (Cohen and Levinthal, 1990) 
that can be related to higher ability of the firm to integrate 
external knowledge into the product development process 
and, consequently, to a smoother adoption of the open 
innovation paradigm. On the other hand, firms with lower 
internal R&D might need more external knowledge. Hence, 
this variable may have contradictory effects on the adoption 
of OI: in literature different studies suggest open innovation 
as either substitute or complementary to internal R&D.
Laursen and Salter (2006) uncovered a negative interaction 
effect between internal R&D and open innovation, which 
might be explained by a greater propensity of research 
intensive firms to exhibit the so-called not-invented-here 
syndrome (Katz and Allen, 1982). In addition, Faems et al. 
(2010) found an indirect relationship between the diversity 
of the technology alliance portfolio and product innovation 
performance via internal R&D intensity.
Conversely, van de Vrande et al. (2009) stated that the 
range of possibilities that open innovation practices offer 
is wider for large SMEs than for small ones since the 
former have more formalized internal R&D and innovation 
practices. In addition, by evaluating the motivations of 
specific types of open innovation, the authors found that 
a vital reason for the outsourcing of R&D is to gain from 
complementary resources in order to spread the risks 
and to compensate for a lack of current R&D capacity. 
Further, Chesbrough and Crowther (2006) also found a 
stable or increased R&D spending in organizations where 
open innovation was adopted, suggesting the role of open 
innovation as a complement for internal R&D. According to 
Lazzarotti et al. (2010), open innovators spend significantly 
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of technology alliance portfolios on financial performance. 
Furthermore, Hwang and Lee (2010) examined the role 
of external knowledge search breadth and depth on 
productivity, calculated as firm total sales divided by the 
number of employees, finding that they both have a significant 
influence on labour productivity. In particular, breadth has 
a U relationship with labour productivity while depth an 
inverse-U relationship. This implies that the moderate use of 
external knowledge sources increases labour productivity, 
but only the limited number of external sources with 
innovative importance are effective in improving it. 
By taking into account not only the benefits of open 
innovation, but also the costs associated with its adoption, 
we posit the following hypothesis.
Hp. 6: Financial performances of companies have an 
inverted-U relationship with open innovation adoption.
All the hypotheses can be summarized in Figure 1.
Ahn et al. (2013) analysed the relationships between open 
innovation capacities and financial performance assessed 
in terms of sales and operating profit, using the Korean 
Innovation Survey 2008 data. The analysis suggests that all 
OI capacities are significantly associated with firms’ financial 
performance but some are negatively associated, implying 
the possibility of delayed effects.
According to Faems et al. (2010), the research has usually 
focused on the value-enhancing effects of OI, but not on 
the increased costs of a more diverse technology alliance 
portfolio. As a matter of fact, when a firm comes to rely 
more on external inputs, its search and partnering costs 
may increase. In particular, in the short-term, the direct cost-
increasing effect of technology alliance portfolio diversity is 
larger than the indirect value-generating effect of technology 
alliances, resulting in an aggregated negative effect of diversity 
Figure 1. The research hypotheses.
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Measures
We adopted a pecuniary approach to the measurement of 
the openness degree of companies, by analysing their OI 
transactions. According to literature (Gassmann and Enkel, 
2004), open innovation is characterized by two different 
dimensions: inbound and outbound. 
On the economic side, inbound transactions include the 
costs deriving from 1) collaborative R&D projects, 2) 
outsourcing of R&D services and 3) in-licensing, and, on 
the financial one, the acquisition of innovation-related 
intangibles (i.e. additions), such as development costs, patents, 
product rights or technology. In the same way, outbound 
transactions include revenues from 1) R&D collaboration, 
2) R&D services performed on behalf of third parties and 
3) out-licensing, as well as the selling of innovation-related 
intangibles (i.e. disposals).
In order to understand how pervasive open innovation 
is within the business of a company, open costs and 
revenues, additions and disposals of intangibles have to be 
compared respectively to total R&D and IP costs, total 
revenues and total intangibles, so that two measures of 
openness can be defined:




In addition to openness metrics, the following context 
variables and financial performances were considered:
• firm size, defined as the number of employees;
• firm age, measured in number of years from the date of 
establishment;
• closed R&D per employee, where closed R&D is measured 
as total R&D and IP costs net of open costs;
• closed EBIT per employee, where closed EBIT is measured 
as EBIT net of open revenues less open costs;
• closed ROA, measured as closed EBIT divided by total 
assets;
• market capitalization on total assets.
The data were used after a cross-section perspective, since 
five years are not enough for a longitudinal study, especially 
in an industry where the development time horizon can be 
longer than ten years.
Research methodology
Sample and data collection
The hypotheses were tested by analysing a sample of bio-
pharmaceutical companies, given the high relevance open 
innovation has in such industry. The industry is, in fact, 
an early pioneer of OI (Cooke, 2005; Chesbrough and 
Crowther, 2006; Fetterhoff and Voelkel, 2006; Kleyn et al., 
2007; Chiaroni et al., 2008) because of the high relevance of 
R&D and the distributed nature of knowledge (Powell et al., 
2005), and has a broad spectrum of OI models which have 
already become a standard in it (Gassmann et al., 2008).
We considered a sample of 126 world top R&D spending 
companies, ranked by The 2011 EU Industrial R&D Investment 
Scoreboard, for which we analysed the consolidated annual 
reports from 2008 to 2012, for a total of 630 statistical units.
The Scoreboard reports 229 bio-pharmaceutical companies, 
but 85 companies were excluded because their annual 
reports, available on the internet, were either incomplete, 
with no notes to the consolidated balance sheet and income 
statement, or not filling IFRS or US GAAP standards. 
Further, 18 companies were excluded since some of their 
annual reports were not available on the internet, because 
they were acquired during the five-years period. The final 
sample consists of 77 European companies and 49 non-
European ones: the most represented country is USA with 
42 companies, followed by UK (14) and Germany (13).
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Context features
Table 2 shows the results of regression analyses performed 
using firm size and age as predictors and inbound and 
outbound as dependent variables.
Empirical results
Table 1 shows descriptive statistics and correlations between 
all the variables under study.
Table 1. Mean, standard deviation and correlations  
(** the correlation is significant at 0,01 level, * the correlation is significant at 0,05 level).
Dependent variable: inbound Dependent variable: outbound
Adjusted R2 ,023 ,214
Std. error of the 
estimate ,205 ,259
ANOVA: Regression Residual Regression Residual
Sum of squares ,702 26,434 11,597 42,093
df 2 627 2 627
Mean square ,351 ,042 5,799 ,067
F 8,327 86,374
Sig. ,000 ,000
Predictors: B Std. error t Sig. B
Std. 
error t Sig.
constant ,214 ,011 19,506 ,000 ,371 ,014 26,837 ,000
firm size -3E-07 ,000 -0,906 ,365 -2E-06 ,000 -3,685 ,000
firm age -,001 ,000 -3,044 ,002 -,002 ,000 -9,259 ,000
Mean SD 1. 2. 3. 4. 5. 6. 7. 8.
1. inbound 18,5% 20,8% 1
2. outbound 25,6% 29,2% ,106** 1
3. firm size 10.340 25.146 -,107** -,330** 1
4. firm age 42 47 -,157** -,446** ,484** 1
5. closed R&D per employee 116 k€
117 
k€
-,165** ,531** -,215** -,359** 1
6. closed EBIT per employee -81 k€
233 
k€
,090* -,689** ,280** ,333** -,671** 1
7. closed ROA -13,5% 39,9% ,070 -,613** ,264** ,346** -,463** ,689** 1
8. market capitalization on 
assets 2,76 17,01 -,031 ,022 -,036 -,043 ,050 -,166** -,212** 1
Table 2. Linear regressions of inbound and outbound using context features as predictors
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Size has no significant effect on inbound and a negative 
effect on outbound, thus Hp. 1 is only partially significant, 
but with the opposite sign. Firm age negatively affects both 
inbound and outbound, so that Hp. 2 is significant with 
the opposite sign.
The difference in the results can be primarily explained 
with the different approach used to define the openness 
of companies. The most widespread measures of openness 
include the number of external sources of knowledge, the 
alliance portfolio diversity and the number of different open 
activities in which a company is involved. All such measures 
increase with the company size, because of the resources 
that can be devoted to the management of different 
relationships, as well as with its age, because of the larger 
number of collaboration opportunities along its life. 
Our approach to the measurement of openness, rather 
than evaluating the wideness of linkages with third parties 
or the number of different open activities, focuses on how 
much OI is pervasive in the company in terms of importance 
for its business, e.g. how much open costs count over total 
R&D and IP costs. Thus, even if a small, young company has 
a limited number of external linkages or performs a limited 
number of open activities, the pecuniary flows deriving 
from such linkages/activities can be very high, especially if 
compared to its total volume of business.
A result consistent with literature would be achieved if, 
instead of measuring openness through ratios, the total 
values of open costs, revenues, additions and disposals were 
used. Actually, the total open flows are typically higher for 
larger companies even if their importance for the total 
business of the company is marginal. For example, in 2012 
Roche achieved about 1,4 billion euro from its open activities 
which, compared to the 39 billion of total revenues, equals 
to 3,6%; on the other side, Sygnis Pharma achieved 100% 
of its 0,4 million euro revenues through open innovation. 
After our approach Sygnis is more open than Roche, since 
OI is a more pervasive behaviour and has a more important 
effect on the business of the former. If total values would be 
used, Roche would be more open than Sygnis and a positive 
relation would be found between openness and firm size.
R&D organization
Hp. 3 is rejected by the use of both frequency and intensity 
(Table 3).
Frequency is the number of companies which adopted open 
practices in the five-years period analysed - i.e. the number 
of non-zero values for inbound and outbound metrics - 
while intensity is the value of the metrics themselves.
In our sample outbound practices are slightly more frequent 
than inbound ones and the mean value of outbound 
transactions - when compared to the total business 
of companies - is slightly higher than the mean value 
of inbound ones.
Once again, if total values of open flows were considered 
instead of ratios, the opposite result would be achieved, with 
inbound transactions totalling 43,7 billion euro costs and 
286,8 billion additions and outbound transactions totalling 
58,1 billion revenues and 13,5 billion disposals.
Ideally, any inbound flow for a company should generate 
an outbound flow for another one, so that the two values 
should be the same. Yet, being our sample limited to only 126 
companies in the bio-pharmaceutical industry we do not 
expect a perfect equality of inbound and outbound flows, 
which is expected only when the total industry is analysed. 
Further, some more explanations can be given to such 
dissymmetry. Comparing revenues and costs points out that 
the former are slightly higher than the latter: this may be due 
to the fact that not all the expenses in R&D are registered 
as costs, since, when accounting criteria are satisfied, they 
can be reported in the balance sheet as capitalization. This 
remark is also consistent with the higher value of additions if 
compared to disposals, even if it is not the unique motivation 
for the disparity. A second reason is, in fact, the presence 
of goodwill (89,0 billion euro) which can be viewed as the 
difference between how much the buyer pays (addition) and 
how much was registered in the balance sheet of the seller 
(disposal). The third motivation is linked to the fact that 
when a whole company is acquired, an addition is registered 
for the acquiring firm, but no disposal can be found, since the 
Table 3. Descriptive statistics for inbound and outbound.
inbound outbound
number of companies 537 584
percentage of companies 85,24% 92,70%
mean value 18,51% 25,61%
72
ISSN: 0718-2724. (http://www.jotmi.org) 
Journal of Technology Management & Innovation © Universidad Alberto Hurtado, Facultad de Economía y Negocios.
J. Technol. Manag. Innov. 2014, Volume 9, Issue 3
acquired company disappears and no annual report is drawn.
Also Hp. 4 is tested as to both frequency and intensity 
and it resulted significant with the opposite sign, i.e. in the 
selected sample companies adopting inbound practices are 
less inclined to adopt outbound ones. Even if correlation 
between inbound and outbound is weakly positive (Table 
1), the regression analysis does not support the causative 
relationship being R2 too low (data not shown). Further, the 
percentage of companies adopting outbound practices in the 
whole sample is slightly lower than the percentage among 
those not adopting inbound practices (Table 4) and the 
mean intensity of outbound in the sub-sample of companies 
not performing inbound is almost two times higher than the 
intensity for companies performing inbound (Table 5). Such 
difference in the mean values is statistically significant, as 
confirmed through the one-way ANOVA (Table 6).
not performing outbound performing outbound total
not performing inbound 3 (3,2%) 90 (96,8%) 93 (100%)
performing inbound 43 (8,0%) 494 (92,0%) 537 (100%)
total 46 (7,3%) 584 (92,7%) 630 (100%)
outbound mean outbound SD
not performing inbound 43,8% 29,4%
performing inbound 22,5% 28,0%
total 25,6% 29,2%
Sum of squares df Mean square F Sig.
Between 
groups 3,627 1 3,627 45,492 ,000
Within groups 50,064 628 ,080
Table 4. Number (percentage) of companies performing and not performing inbound and outbound activities: crosstab
Table 5. Outbound mean and standard deviation for companies performing and not performing inbound activities.
Table 6. One-way ANOVA for outbound using inbound as a predictor.
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Financial performances
In order to test the inverted-U shape of performances, 
quadratic regressions were performed with closed EBIT per 
employee, closed ROA and market capitalization on assets 
as dependent variables and inbound, outbound, their squares 
and their product as predictors.
Both closed EBIT per employee and closed ROA provide 
a partial confirmation to Hp. 6 (Table 8), while market 
capitalization on assets regression is not significant 
(data not shown).
In particular, the hypothesis is confirmed as to inbound, since 
the first-power term has a positive coefficient, the second-
power one a negative coefficient. On the contrary, the 
coefficients of outbound suggest an opposite trend, i.e. an U 
shape. The trends of closed EBIT per employee vs. inbound 
(outbound) for different values of outbound (inbound) are 
reported in Figure 2a (b). Similar trends are obtained for 
closed ROA (figures not shown).
Once again, the results would be different if we considered 
the total values of OI flows instead of ratios: the total value 
of open revenues for the companies adopting inbound 
practices is 55,5 billion euro versus 2,6 billion euro for those 
non performing inbound; an even more significant difference 
is registered as to disposals (13,2 vs. 0,2 billion).
Hp. 5a is significant with the opposite sign while Hp. 5b is 
confirmed (Table 7). 
Inbound practices were found to be substitutive to 
internal R&D, while outbound ones can be considered 
complementary. Actually, inbound activities and internal R&D 
both represent efforts that a company puts in its innovation 
process, while outbound practices can be considered as a 
result of such process. Thus, if the two typologies of input 
- internal resources vs. external ones - can be considered 
as substitutive, it is not surprising that a higher level of 
internal R&D generates more innovation outputs that can 
be exploited through outbound practices.
Table 7. Linear regression of closed R&D per employee using inbound and outbound as predictors.
Dependent variable: closed R&D per employee
Adjusted R2 ,329
Std. error of the 
estimate 95,607
ANOVA: Regression Residual
Sum of squares 2.836.868 5.731.248
df 2 627
Mean square 1.418.434 9.141
F 155,177
Sig. ,000
Predictors: B Std. error t Sig.
constant 82,516 5,918 13,943 ,000
inbound -125,920 18,458 -6,822 ,000
outbound 221,445 13,122 16,875 ,000
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for any value of outbound greater than or equal to 20% 
a negative EBIT should be expected. This is confirmed by 
the trends in Figure 2b, where closed EBIT per employee 
is positive only for outbound less than or equal to 18%. 
The curves with inbound less than 60% show a decreasing 
trend vs. outbound, while when inbound is greater than 
or equal to 60% the performances have an U shape, 
reaching a minimum and then increasing for values of 
outbound greater than 85%.
It is possible to observe that, for any fixed value of 
outbound, both performance indicators increase with the 
value of inbound until a maximum is reached and then 
begin to decrease. Closed EBIT per employee reaches its 
maximum for values of inbound ranging from 43%, when 
outbound is equal to zero, to 58%, when outbound is equal 
to 100%. It is noteworthy that only the curve corresponding 
to no outbound shows positive values of the ratio, so that 
Dependent variable: closed EBIT per employee Dependent variable: closed ROA
Adjusted R2 ,521 ,421
Std. error of the 
estimate
161,314 ,304
ANOVA: Regression Residual Regression Residual
Sum of squares 17.957.960 16.237.922 42,569 57,545
df 5 624 5,000 624,000
Mean square 3.591.592 26.022 8,514 0,092
F 138,020 92,321
Sig. ,000 ,000
Predictors: B Std. error t Sig. B Std. error t Sig.
constant 26,224 13,258 1,978 ,048 5,664 2,496 2,269 ,024
inbound 5,003 ,942 5,312 ,000 ,658 ,177 3,711 ,000
outbound -8,689 1,154 -7,526 ,000 -1,718 ,217 -7,903 ,000
inbound2 -,061 ,013 -4,528 ,000 -0,009 ,003 -3,514 ,000
outbound2 ,039 ,016 2,408 ,016 0,011 0,003 3,634 ,000
inbound*outbound ,021 ,010 1,996 ,046 ,005 ,002 2,664 ,008
Table 8. Quadratic regressions of closed EBIT per employee and closed ROA using inbound and outbound as predictors.
Figure 2. Iso-outbound (a) and iso-inbound (b) curves for closed EBIT per employee.
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The trends of closed ROA are quite similar, with maximum 
values reached for inbound ranging from 37% to 67% and 
positive values only for outbound less than or equal to 
13%. Yet, all the iso-inbound curves here have an U shape, 
with an increase of performances for outbound greater 
than or equal to 54%.
A slight recourse to inbound practices provides benefits in 
terms of costs reduction: companies can access external 
resources at a lower cost than the one they would incur if 
only internal resources were used. Yet, when the recourse to 
external resources increases, the management complexity 
of such resources is higher than the benefits, thus resulting 
in an increase of costs.
As to outbound, the negative relation with performances 
can be considered as industry-specific. Actually, high values 
of outbound are typical of biotech companies which are 
mostly focused on the R&D process and only seldom 
commercialize products. Thus, a consistent part of their 
revenues derive from OI activities such as the selling of R&D 
services or the licensing of their IP: 19 companies out of 
126 in the sample gain 100% of their revenues from open 
innovation in at least one of the five years. These companies 
are typically in loss and survive only from private investments 
and government contributions.
A final remark has to be done as to the coefficient of  the 
product of inbound and outbound that, being positive, implies 
a synergy between open modalities, with performances 
increasing when both inbound and outbound are performed.
In Table 9 a summary of our results is provided.
Conclusions
The paper analyses the relationship between the adoption of 
open innovation by companies and their 1) context features, 
2) R&D organization and 3) financial performances.
Our results suggest that open innovation is more pervasive 
among small and young biotech companies, for most of 
which it is the very core business with most part of revenues 
deriving from open practices. Yet, higher contributions in 
terms of total open costs, revenues, additions and disposals 
are provided by large companies: despite open innovation is 
not a core activity for them and can be defined as an ancillary 
activity, due to their larger dimension, higher volumes are 
exchanged by them in the innovation market.
Even if the number of companies performing inbound and 
outbound practices is quite similar, the former have a higher 
entity, the latter a higher intensity. This means that the 
cumulative value of costs and additions is higher than the 
cumulative value of revenues and disposals, but, when the 
four entities are compared to the total volume of business, 
outbound is more relevant than inbound. 
Inbound practices are substitutive to internal R&D activities, 
while outbound ones are complementary to internal 
development: the former provide external knowledge 
resources as alternative to internal ones, the latter represent 
the exploitation of innovation results obtained with both 
internal and external resources.
Table 9. Summary of the results.
Hypothesis Results
Hp. 1 Partially significant, but opposite 
sign
Hp. 2 Significant, but opposite sign
Hp. 3 No support
Hp. 4 Significant, but opposite sign
Hp. 5a Significant, but opposite sign
Hp. 5b Confirmed
Hp. 6 Partially confirmed
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The performances of companies have an inverted-U 
shape trend versus inbound practices and a fundamentally 
decreasing trend versus outbound ones: beyond a certain 
value of inbound the benefits deriving from leveraging 
external technologies are exceeded by the costs deriving 
from the management of external relationships; on the 
other side, the negative relation between performances 
and outbound practices can be considered as industry-
specific since high values of outbound are typical 
of biotech companies.
The paper contributes to the debate on open innovation 
in two ways. First, by suggesting a measurement framework 
for OI based on its pecuniary dimension, it provides new 
insights as to what “being open” means for a company. 
Actually, most contributions in literature provide a definition 
of openness linked to the wideness and diversity of open 
activities and/or alliances portfolio, while our definition is 
basically linked to how much such activities and alliances 
influence the business of companies, i.e. how pervasive is 
openness in the business models of companies. Noteworthy, 
the two different approaches to openness often lead to 
different results in terms of relationships with structural 
configurations and performances. The second contribution, 
in line with the suggestion by Schroll and Mild (2011), is the 
separation of inbound from outbound activities, which leads 
to a deeper understanding of open innovation. 
Three limits can be outlined for the work. First, the 
disharmony of accounting standards over countries limited 
our analysis only to the companies which adopted either 
IFRS or US GAAP, resulting in an under-coverage of the 
sample. Second, being focused on accounting indicators, 
our framework can be used to analyse only the pecuniary 
dimension of open innovation (Dahlander and Gann, 2010) 
and thus it cannot be generalized to such industries as 
software, where sourcing and revealing are widespread. 
Third, the paper is based on observations over a five-years 
period, which is too short, at least in the analysed industry, 
to allow a longitudinal analysis.
Further directions of research will be devoted to in-
depth case studies over longer periods of time, in order 
to describe the different trajectories to open innovation 
within the specific industry and understand how open 
strategies can be related to company’s culture. Moreover, 
the widening of the analysis to the technology hardware 
and equipment (THE) sector highlighted very different OI 
adoption models (Michelino et al. 2014b); the validation of 
the suggested  hypotheses for  the THE industry is now 
under investigation.
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COMPANY INDUSTRY COUNTRY COMPANY INDUSTRY COUNTRY COMPANY INDUSTRY COUNTRY
4SC biotech D Illumina biotech USA Teva pharma IL
Abbott pharma USA Impax biotech USA Theravance pharma USA




Actelion pharma CH Innate biotech F TiGenix biotech B
Active biotech S Intercell biotech A TopoTarget biotech DK
Affymetrix biotech USA Ipsen pharma F Transgene biotech F
Alexion biotech USA Isis biotech USA UCB pharma B
ALK-Abello pharma DK J&J pharma USA United biotech USA
Alkermes pharma USA Krka pharma SLO Vectura pharma UK
Allergan pharma USA Lab Rovi pharma E Vernalis biotech UK
Almirall pharma E Lexicon biotech USA Vertex biotech USA
Amgen biotech USA Life Tech biotech USA Vetoquinol pharma F
Arena pharma USA Lundbeck pharma DK Warner pharma IRL
Ark biotech UK Meda pharma S Wilex biotech D
AstraZeneca pharma UK Medicines pharma USA Zealand biotech DK
Basilea biotech CH MediGene biotech D Zeltia pharma E
Bavarian biotech DK Medivir pharma S
Biogen biotech USA Merck DE pharma D
Bioinvent biotech S Merck US pharma USA
Biomarin biotech USA Merz pharma D
Biotest pharma D Morphosys biotech D
Biotie biotech FIN Mylan pharma USA
Bioton pharma PL Nektar biotech USA
Boehringer pharma D NeuroSearch biotech DK
Bristol-MS pharma USA Newron biotech I
BTG biotech UK NicOx pharma F
Celgene biotech USA Novartis pharma CH
CHR pharma DK NovoNordisk pharma DK
Cosmo pharma I Novozymes biotech DK
CSL biotech AUS NPS biotech USA
Cubist biotech USA Oasmia pharma S
Dechra pharma UK Omega pharma B
Dendreon biotech USA Onyx pharma USA
Diamyd pharma S Orexo pharma S
DiaSorin pharma I Orion Oyj pharma FIN
Egis pharma H Oxford pharma UK
Elan pharma IRL Paion biotech D
Eli Lilly pharma USA Perrigo pharma USA
Endo pharma USA Pfizer pharma USA
Epigenomics biotech D Pharming biotech NL
Evotec pharma D Qiagen  biotech NL
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Exelixis pharma USA Recordati pharma I
Forest pharma USA Regeneron biotech USA
Galapagos biotech B Roche pharma CH
Galenica pharma CH Salix pharma USA
Gedeon pharma H Sanofi-Aventis pharma F
Genmab biotech DK Seattle biotech USA
Genus biotech UK Shire pharma UK
Geron biotech USA Silence biotech UK
Gilead biotech USA SkyePharma pharma UK
GSK pharma UK SOB biotech S
Guerbet pharma F Stada pharma D
GW pharma UK Sygnis biotech D
Hikma pharma UK Symphogen biotech DK
Hospira pharma USA Targacept biotech USA
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